ARTICLE | Clinical News
AVNC enrolls another Amoxicillin Pulsys Phase III
April 23, 2005 1:02 AM UTC
Advancis (AVNC) completed enrollment of 571 pediatric patients in an investigator-blind, U.S. Phase III trial of a "sprinkle" formulation of Amoxicillin Pulsys to treat acute tonsilitis/pharyngitis. T...